An Exploratory Clinical Study on Single Subretinal Injection of ZVS101e (rAAV2/8-hCYP4V2) Into Eyes With Bietti's Crystalline Dystrophy (BCD)
Latest Information Update: 14 Feb 2023
At a glance
- Drugs ZVS 101e (Primary)
- Indications Bietti crystalline dystrophy
- Focus Adverse reactions
Most Recent Events
- 14 Feb 2023 New trial record